Diminishing microbiome richness and distinction in the lower respiratory tract of lung cancer patients: A multiple comparative study design with independent validationJing Jin, Yuncui Gan, Huayong Liu et al.|Lung Cancer|2019Cited by 102
Screening of potential protein biomarkers in Bronchoalveolar Lavage Fluid (BALF) for early-stage lung adenocarcinoma with diagnostic value by Liquid chromatography MS analysis (LC-MS/MS)Huohuan Tian, Dan Liu, Linhui Yang et al.|Unknown|2023Cited by 0
254 (PB242): HMPL-500, a potent and selective EZH1/EZH2 dual inhibitor, demonstrates superior anti-tumor activity in preclinical models of hematological malignancies and solid tumorsLiang Ge, Wei Su, Shaohua Chen et al.|European Journal of Cancer|2024Cited by 0